- What is SBI JI Innovation Fund's primary investment focus?
- SBI JI Innovation Fund is a biopharma-focused venture capital fund. It cherry-picks Israeli or Israel-related venture-backed biopharma companies across different developmental stages.
- When was SBI JI Innovation Fund founded?
- SBI JI Innovation Fund was formed in early 2017 as a partnership between SBI Holdings and Vertex.
- Which sectors does SBI JI Innovation Fund primarily invest in?
- SBI JI Innovation Fund primarily invests in Health Tech & Life Sciences, with some investments also in Cyber Security and Fintech & Insurtech.
- Can you name some notable portfolio companies of SBI JI Innovation Fund?
- Notable portfolio companies include Ayala Pharmaceuticals, which focuses on targeted therapies for rare cancers, and BiomX, which develops microbiome therapies for chronic diseases.
- Has SBI JI Innovation Fund had any notable exits?
- Yes, SBI JI Innovation Fund has had exits, including Chemomab Therapeutics via a Reverse Merger Event in March 2021 and Ayala Pharmaceuticals via a PO Event in May 2020.
- What investment stages does SBI JI Innovation Fund typically participate in?
- SBI JI Innovation Fund participates in a range of investment stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- Who are the founding partners of SBI JI Innovation Fund?
- The founding partners of SBI JI Innovation Fund include Masa Tanaka, David HELLER, and Ran Gartenberg.
- What is the geographic focus of SBI JI Innovation Fund's investments?
- SBI JI Innovation Fund focuses on Israeli or Israel-related venture-backed biopharma companies.